Lu Wang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Biological Psychiatry top 5%
Papers in
-
- Inflammasome and immune disorders 15
- Extracellular vesicles in disease 6
-
- MicroRNA in disease regulation 10
- Cancer, Hypoxia, and Metabolism 6
- Co-authors
- Hao Zhang (13 shared papers)Hui‐Chuan Sun (7 shared papers)Wei‐Zhong Wu (4 shared papers)Zhao–You Tang (3 shared papers)Xiao Xiong (9 shared papers)Xiao‐Dong Zhu (2 shared papers)Ling–Qun Kong (2 shared papers)Huaxiang Xu (2 shared papers)
- Journals
- Cancer Letters (3 papers)Clinical Cancer Research (3 papers)Oncogene (2 papers)Cancer Management and Research (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Lu Wang
138 papers receiving 3.2k citations
Lu Wang's Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 579
- Biological Psychiatry 64
- Immunology 502
- Molecular Biology 1.5k
- Oncology 522
Countries citing papers authored by Lu Wang
This map shows the geographic impact of Lu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Wang more than expected).
Fields of papers citing papers by Lu Wang
This network shows the impact of papers produced by Lu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Wang. The network helps show where Lu Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 341 | |
| 2 | 2019 | 193 | |
| 3 | A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study Hit paper breakdown → | 2022 | 149 |
| 4 | 2014 | 147 | |
| 5 | 2020 | 120 | |
| 6 | 2013 | 90 | |
| 7 | 2011 | 84 | |
| 8 | 2005 | 76 | |
| 9 | Gut dysbiosis induces the development of depression-like behavior through abnormal synapse pruning in microglia-mediated by complement C3 Hit paper breakdown → | 2024 | 74 |
| 10 | 2017 | 73 | |
| 11 | 2006 | 71 | |
| 12 | 2016 | 69 | |
| 13 | 2018 | 66 | |
| 14 | 2016 | 61 | |
| 15 | 2012 | 61 | |
| 16 | 2013 | 60 | |
| 17 | 2003 | 49 | |
| 18 | 2022 | 46 | |
| 19 | 2023 | 43 | |
| 20 | 2014 | 43 |
About Lu Wang
Lu Wang is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Pulmonary and Respiratory Medicine, having authored 148 papers that have together received 3.2k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (15 papers), MicroRNA in disease regulation (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), interferon and immune responses (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Extracellular vesicles in disease (6 papers), Immune cells in cancer (5 papers) and Freshwater macroinvertebrate diversity and ecology (5 papers). The work is most often cited by research in Cancer Research (579 citations), Biological Psychiatry (64 citations), Immunology (502 citations), Molecular Biology (1.5k citations) and Oncology (522 citations). Lu Wang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Hao Zhang, Hui‐Chuan Sun, Wei‐Zhong Wu, Zhao–You Tang, Xiao Xiong, Xiao‐Dong Zhu, Ling–Qun Kong, Huaxiang Xu, Peng–Yuan Zhuang and Yuquan Xiong. Their work appears in journals such as Cancer Letters, Clinical Cancer Research, Oncogene, Cancer Management and Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.